全文获取类型
收费全文 | 4071篇 |
免费 | 221篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 184篇 |
妇产科学 | 86篇 |
基础医学 | 436篇 |
口腔科学 | 69篇 |
临床医学 | 256篇 |
内科学 | 1112篇 |
皮肤病学 | 133篇 |
神经病学 | 336篇 |
特种医学 | 149篇 |
外科学 | 671篇 |
综合类 | 21篇 |
预防医学 | 156篇 |
眼科学 | 23篇 |
药学 | 266篇 |
中国医学 | 4篇 |
肿瘤学 | 375篇 |
出版年
2024年 | 3篇 |
2023年 | 36篇 |
2022年 | 8篇 |
2021年 | 33篇 |
2020年 | 26篇 |
2019年 | 34篇 |
2018年 | 50篇 |
2017年 | 42篇 |
2016年 | 55篇 |
2015年 | 65篇 |
2014年 | 66篇 |
2013年 | 81篇 |
2012年 | 347篇 |
2011年 | 328篇 |
2010年 | 122篇 |
2009年 | 102篇 |
2008年 | 295篇 |
2007年 | 293篇 |
2006年 | 306篇 |
2005年 | 335篇 |
2004年 | 311篇 |
2003年 | 286篇 |
2002年 | 242篇 |
2001年 | 165篇 |
2000年 | 213篇 |
1999年 | 104篇 |
1998年 | 53篇 |
1997年 | 36篇 |
1996年 | 38篇 |
1995年 | 31篇 |
1994年 | 20篇 |
1993年 | 21篇 |
1992年 | 8篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1989年 | 16篇 |
1988年 | 18篇 |
1987年 | 19篇 |
1986年 | 15篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 3篇 |
1982年 | 12篇 |
1981年 | 12篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1954年 | 1篇 |
1943年 | 1篇 |
排序方式: 共有4302条查询结果,搜索用时 31 毫秒
61.
62.
A case of dysgraphia induced by sertraline and a review of official spontaneous adverse reaction databases
下载免费PDF全文
![点击此处可从《Journal of clinical pharmacy and therapeutics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
63.
64.
65.
Salvatore Fundarò M.D. Andrea Spallanzani M.D. Dr. Elio Ricchi M.D. Alfonso Carriero M.D. Stefano Perrone M.D. Giulia Giusti M.D. Alberto Giannetti M.D. GianCarlo De Bernardinis M.D. 《Diseases of the colon and rectum》1998,41(1):111-114
AIM: We present a case of squamous-cell carcinoma developing within perianal lichen planus. This is a chronic or recurrent cutaneous and/or mucosal dermatosis affecting less than 1 percent of the population. Neoplastic degeneration of cutaneous lichen planus is rare; only one case of squamous-cell carcinoma developing within perianal lichen planus has been described up until now in the international literature. CASE REPORT: Our case involved a 68-year-old woman with chronic, long-term lichen planus spreading all over the vulva and perianal region and the mucosa of the anal canal, where squamous-cell carcinoma developed within the perianal lichen planus. Treatment consisted of wide, circular excision of the perianal skin and mucosectomy of the anal canal up to as far as 1 cm above the dentate line. Reconstruction was performed by means of two V-Y bilateral subcutaneous flaps. CONCLUSION: Wide excision was performed not only to remove the squamous-cell carcinoma but also the lichen planus to prevent recurrence of metachronous or synchronous squamous-cell carcinoma. Follow-up at one year after surgery showed no local recurrence of either lichen planus or squamous-cell carcinoma, which suggests that surgical removal should be the therapy of choice for long-term, chronic perianal lichen planus that has proved to be resistant to medical therapy. 相似文献
66.
Lord BI; Woolford LB; Wood LM; Czaplewski LG; McCourt M; Hunter MG; Edwards RM 《Blood》1995,85(12):3412-3415
BB-10010 is a genetically engineered variant of human macrophage inflammatory protein-1 alpha with improved solution properties. We show here that it mobilizes stem cells into the peripheral blood. We investigated the mobilizing effects of BB-10010 on the numbers of circulating 8-day spleen colony-forming units (CFU-S8), CFU-S12, and progenitors with marrow repopulating ability (MRA). A single subcutaneous dose of BB-10010 caused a twofold increase in circulating numbers of CFU-S8, CFU-S12, and MRA 30 minutes after dosing. We also investigated the effects of granulocyte colony-stimulating factor (G- CSF) and the combination of G-CSF with BB-10010 on progenitor mobilization. Two days of G-CSF treatment increased circulating CFU-S8, CFU-S12, and MRA progenitors by 25.7-, 19.8-, and 27.7-fold. A single administration of BB-10010 after 2 days of G-CSF treatment increased circulating CFU-S8, CFU-S12, and MRA even further to 38-, 33-, and 100- fold. Splenectomy resulted in increased circulating progenitor numbers but did not change the pattern of mobilization. Two days of treatment with G-CSF then increased circulating CFU-S8, CFU-S12, and MRA by 64-, 69-, and 32-fold. A single BB-10010 administration after G-CSF treatment further increased them to 85-, 117-, and 140-fold, respectively, compared with control. We conclude that BB-10010 causes a rapid increase in the number of circulating hematopoietic progenitors and further enhances the numbers induced by pretreatment with G-CSF. BB- 10010 preferentially mobilized the more primitive progenitors with marrow repopulating activity, releasing four times the number achieved with G-CSF alone. Translated into a clinical setting, this improvement in progenitor cell mobilization may enhance the efficiency of harvest and the quality of grafts for peripheral blood stem cell transplantation. 相似文献
67.
New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation
下载免费PDF全文
![点击此处可从《Pediatric blood & cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Javid Gaziev MD Antonella Isgrò MD Alessia Francesca Mozzi PhD Aurèlie Petain PhD Laurent Nguyen MD Cristiano Ialongo MD PhD Vincenzo Dinallo PhD Pietro Sodani MD Marco Marziali MD Marco Andreani PhD Manuela Testi PhD Katia Paciaroni MD Cristiano Gallucci MD Gioia De Angelis MD Cecilia Alfieri MD Michela Ribersani MD Guido Lucarelli MD 《Pediatric blood & cancer》2015,62(4):680-686
68.
Pozzilli P Crinò A Schiaffini R Manfrini S Fioriti E Coppolino G Pitocco D Visalli N Corbi S Spera S Suraci C Cervoni M Matteoli MC Patera IP Ghirlanda G;IMDIAB Group 《Diabetes technology & therapeutics》2003,5(6):965-974
In a pilot study, the metabolic effects of continuous subcutaneous insulin infusion (CSII) versus intensive subcutaneous insulin therapy (ISIT) started at diagnosis in patients with Type 1 diabetes and continued for a 2-year period were evaluated and compared. Twenty-three patients (between 12 and 35 years old, mean +/- SD 18.4 +/- 9 years) were randomized into two treatment groups (CSII vs. ISIT), and both received supplemental nicotinamide (NA), 25 mg/kg of body weight. CSII was started immediately after admission to the hospital. Parameters of metabolic control [insulin dose, hemoglobin A1c (HbA1c), and C-peptide] were evaluated for a 2-year follow-up period. Data are presented for a total of 19 patients who remained in the study for its duration. Two years after diagnosis, mean +/- SD HbA1c was 6.3 +/- 0.5% and 6.2 +/- 0.3% for the CSII and ISIT groups, respectively (p=not significant). Compared with baseline values, an increase of baseline C-peptide of 38% for the CSII group and 27% for the ISIT group was observed; however, the difference between the groups was not significant. The insulin requirement for the entire duration of the study, but not at entry and 3 months, was significantly higher in CSII compared with ISIT patients (0.62 +/- 0.4 IU/kg/day vs. 0.3 +/- 0.4 IU/kg/day, respectively; p<0.01). After trial completion patients on CSII continued with this mode of therapy. Implementation of CSII as well as ISIT at diagnosis of Type 1 diabetes and continuation for 2 years thereafter achieved similar and optimal metabolic control, but more insulin was required with the CSII group. Both types of intensive insulin therapy combined with NA are able to preserve C-peptide secretion or even increase baseline levels for up to 2 years after diagnosis. 相似文献
69.
Davide Castagno MD PhD Paolo Di Donna MD Iacopo Olivotto MD Antonio Frontera MD Leonardo Calò MD Marco Scaglione MD Anna Arretini MD Matteo Anselmino MD PhD Carla Giustetto MD Gaetano Maria De Ferrari MD Franco Cecchi MD Michel Haissaguerre MD Fiorenzo Gaita MD 《Journal of cardiovascular electrophysiology》2021,32(3):657-666
70.
Pasquale Vergara MD PhD Carlo Pignalberi MD Ennio C. Pisanò MD Giampiero Maglia MD Paolo Della Bella MD Gabriele Zanotto MD Saverio Iacopino MD Francesco Solimene MD Valeria Calvi MD Massimiliano Marini MD Massimo Giammaria MD Mauro Biffi MD Giovanni Rovaris MD Fabrizio Caravati MD Fabio Quartieri MD Antonio Curnis MD Antonio Rapacciuolo MD PhD Gaetano Senatore MD Stefano Pedretti MD Davide Saporito MD Antonio Dello Russo MD Vincenzo E. Santobuono MD PhD Patrizia Pepi MD Antonio Duca MD Matteo Baroni MD Giulio Falasconi MD Daniele Giacopelli MSc Alessio Gargaro MSc Antonio D'Onofrio MD 《Journal of cardiovascular electrophysiology》2021,32(9):2528-2535